A vaccine targeting resistant tumours by dual T cell plus NK cell attack-Reference-Cited by-同舟云学术

A vaccine targeting resistant tumours by dual T cell plus NK cell attack

Published:2022-05-25 Issue:7916 Volume:606 Page:992-998
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Badrinath Soumya,Dellacherie Maxence O.,Li Aileen,Zheng Shiwei,Zhang Xixi,Sobral Miguel,Pyrdol Jason W.,Smith Kathryn L.^ORCID,Lu Yuheng,Haag Sabrina,Ijaz Hamza,Connor-Stroud Fawn,Kaisho Tsuneyasu^ORCID,Dranoff Glenn,Yuan Guo-Cheng^ORCID,Mooney David J.^ORCID,Wucherpfennig Kai W.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-022-04772-4.pdf

Reference41 articles.

1. Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707–723 (2017).

2. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186–1190 (2005).

3. Lanier, L. L. NKG2D receptor and its ligands in host defense. Cancer Immunol. Res. 3, 575–582 (2015).

4. Kaiser, B. K. et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447, 482–486 (2007).

5. Bahram, S., Bresnahan, M., Geraghty, D. E. & Spies, T. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl Acad. Sci. USA 91, 6259–6263 (1994).

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propylene glycol alginate sodium sulfate suppressed lung metastasis by blocking P-selectin to recruit CD4 regulatory T cells;International Journal of Biological Macromolecules;2024-11

2. Spatiotemporal coordination of antigen presentation and co-stimulatory signal for enhanced anti-tumor vaccination;Journal of Controlled Release;2024-10

3. Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis;Journal of Nanobiotechnology;2024-09-14

4. Engineering CaP-Pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations;Journal of Controlled Release;2024-09

5. Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors;Biomaterials;2024-09